Sheharyar Raza et al on Factor XIII Supplementation in Postpartum Hemorrhage
Sheharyar Raza, Transfusion Medicine Specialist and Data Scientist at University Health Network, shared on LinkedIn:
“Clots are bricks (platelets) and cement (fibrin). When we can’t maintain fibrin, severe bleeding can ensue. This is a major driver of postpartum hemorrhage, the leading cause of maternal death during childbirth globally.
In a new article, co-authors Jeremy Jacobs et al critically review the pathophysiology of postpartum hemorrhage, emphasizing fibrin breakdown and the potential role of clotting Factor XIII therapy in cases of severe, refractory bleeding.
Read open access.”
Title: Factor XIII Supplementation in Postpartum Hemorrhage: From Biological Rationale to Clinical Implementation
Authors: Jeremy W. Jacobs, Elizabeth A. Abels, Brian D. Adkins, Garrett S. Booth, Victoria Costa, Sheharyar Raza, Michelle Simon, Jennifer S. Woo, Allison P. Wheeler
More posts featuring Sheharyar Raza on Hemostasis Today.
-
Oct 13, 2026, 02:01Nour Al-Mozain: Is It Really Anti-D? – Unraveling Auto-Anti-LW in the Transfusion Laboratory
-
Oct 13, 2026, 01:51Berenice Villegas: The Role of Morphologic Evaluation in Body Fluid Differential Analysis
-
Oct 13, 2026, 01:44Debadrita Ray: Evaluating vWF and VITRO Score for Detecting CSPH in cACLD Patients
-
Oct 13, 2026, 01:34Nagesh Ramesh: Donating Blood for International Plasma Awareness Week
-
Oct 12, 2026, 21:51Sam Botchey: Orthobiologics Are Advancing but the Evidence Must Keep Pace
-
Oct 12, 2026, 21:50Serum Vitamin D, Platelet Function, and Bleeding in Primary ITP – Platelets Journal
-
Oct 12, 2026, 21:30Nika Samadzadeh Tabrizi: Looking Forward to the PACeS Trial on Anticoagulation for POAF
-
Oct 12, 2026, 21:28Michael Megaly: Does Coronary Ectasia Affect Outcomes in Acute Coronary Syndromes?
-
Oct 12, 2026, 21:25Vitor Borin P. de Souza: Think Twice Before Anticoagulating an Isolated Subsegmental PE